tiprankstipranks

Anna Protopapas Insider Profile

11 Followers
Anna Protopapas, Director at Ariad, holds 2.50K shares in Nuvalent (Ticker: NUVL), holds 380.10K shares in Mersana Therapeutics (Ticker: MRSN), holds 0.00 shares in Bioverativ Inc (Ticker: BIVV).
tipranks
Anna Protopapas

Anna Protopapas
Ariad (ARIA)
Director

Not Ranked
Anna Protopapas has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$946K
79.14%
20.86%
A breakdown of Anna Protopapas's holdings

Insider Roles

Mersana Therapeutics
(MRSN)
Director
Nuvalent
(NUVL)
Director
Roles that Anna Protopapas holds in companies

Most Profitable Insider Trade

Stock:
Nuvalent
(NUVL)
Rating:Informative Sell
Date:Dec 20, 2023 - Today
Return:-9.50%
The most profitable trade made by Anna Protopapas

Anna Protopapas's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARIA
Ariad
Feb 16, 2017
Uninformative Sell
$573.41K
Mersana Therapeutics
Jan 17, 2024
Director
Uninformative Buy
173.83K
$748.80K
BIVV
Bioverativ Inc
Mar 08, 2018
Uninformative Sell
$0.00
DRNA
Dicerna Pharma
$127.39K
Nuvalent
Jun 14, 2024
Director
Uninformative Buy
$197.32K
List of latest transactions for each holding click on a transaction to see Anna Protopapas's performance on stock

Anna Protopapas insider profile FAQ

What is the percentage of profitable transactions made by Anna Protopapas?
The percentage of profitable transactions made by Anna Protopapas is ―.
    What is the average return per transaction made by Anna Protopapas?
    The average return per transaction made by Anna Protopapas is ―.
      What stocks does Anna Protopapas hold?
      Anna Protopapas holds: ARIA, MRSN, BIVV, DRNA, NUVL stocks.
        What was Anna Protopapas’s latest transaction?
        Anna Protopapas latest transaction was an Uninformative Buy of ―.
          What was Anna Protopapas's most profitable transaction?
          Anna Protopapas’s most profitable transaction was an Informative Sell of NUVL stock on December 20, 2023. The return on the trade was -9.50%.
            What is Anna Protopapas's role in Ariad?
            Anna Protopapas's role in Ariad is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.